CUBE vs LAB
CubeSmart (CUBE) versus Standard Biotools Inc (LAB) — a side-by-side from cached financials, not a winner call.
CubeSmart (CUBE) is a reit - industrial company listed on US.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
Latest reported CUBE revenue for 2024-12-31 was $1.07B. Net income was $391.9M. Revenue was up 1.5% from 2023-12-31 to 2024-12-31. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
CUBE currently screens at market cap $9.69B and trailing P/E 25.0. LAB currently screens at market cap $317.1M.
Not investment advice. Open the CUBE and LAB stock pages for the full models.
Not investment advice.